Login to Your Account

U.S. Patent Disclosures

Monday, February 28, 2011
Vermillion Inc., of Austin, Texas, received U.S. Patent No. 7,867,719 titled, "Beta-2 microglobulin as a biomarker for peripheral artery disease." Vermillion also received a notice of allowance for a patent titled, "Biomarkers for breast cancer."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription